谷歌浏览器插件
订阅小程序
在清言上使用

High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals

Journal of Hepatology(2016)

引用 9|浏览27
暂无评分
关键词
sofosbuvir/velpatasvir,treatment-experienced,hcv-infected,direct-acting
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要